Last reviewed · How we verify

clindamycin phosphate/butoconazole nitrate — Competitive Intelligence Brief

clindamycin phosphate/butoconazole nitrate (clindamycin phosphate/butoconazole nitrate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibiotic and antifungal combination. Area: Fungal infections, Bacterial infections.

phase 3 Antibiotic and antifungal combination Fungal infections, Bacterial infections Small molecule Live · refreshed every 30 min

Target snapshot

clindamycin phosphate/butoconazole nitrate (clindamycin phosphate/butoconazole nitrate) — Lumara Health, Inc.. Clindamycin phosphate/butoconazole nitrate is an antibiotic and antifungal combination that works by inhibiting bacterial cell wall synthesis and disrupting fungal cell membranes.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
clindamycin phosphate/butoconazole nitrate TARGET clindamycin phosphate/butoconazole nitrate Lumara Health, Inc. phase 3 Antibiotic and antifungal combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibiotic and antifungal combination class)

  1. Lumara Health, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). clindamycin phosphate/butoconazole nitrate — Competitive Intelligence Brief. https://druglandscape.com/ci/clindamycin-phosphate-butoconazole-nitrate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: